Surmodics ROA 2006-2018 | SRDX

Current and historical return on assets (ROA) values for Surmodics (SRDX) over the last 10 years. Return on assets can be defined as an indicator of how profitable a company is relative to its total assets. Calculated by dividing a company's operating earnings by its total assets. Surmodics ROA for the three months ending September 30, 2018 was 4.34%.
Surmodics ROA - Return on Assets Historical Data
Date TTM Net Income Total Assets Return on Assets
2018-09-30 $-0.01B $0.16B -3.22%
2018-06-30 $-0.00B $0.16B -2.02%
2018-03-31 $0.00B $0.16B 0.71%
2017-12-31 $0.00B $0.14B 0.00%
2017-09-30 $0.00B $0.14B 3.02%
2017-06-30 $0.01B $0.13B 5.33%
2017-03-31 $0.01B $0.13B 7.69%
2016-12-31 $0.01B $0.13B 7.83%
2016-09-30 $0.01B $0.13B 8.91%
2016-06-30 $0.01B $0.13B 7.83%
2016-03-31 $0.01B $0.12B 8.39%
2015-12-31 $0.01B $0.11B 11.06%
2015-09-30 $0.01B $0.10B 12.87%
2015-06-30 $0.01B $0.10B 13.72%
2015-03-31 $0.01B $0.09B 13.54%
2014-12-31 $0.01B $0.09B 12.34%
2014-09-30 $0.01B $0.11B 12.09%
2014-06-30 $0.01B $0.10B 14.21%
2014-03-31 $0.01B $0.10B 13.10%
2013-12-31 $0.02B $0.10B 14.67%
2013-09-30 $0.02B $0.10B 14.22%
2013-06-30 $0.01B $0.10B 13.21%
2013-03-31 $0.01B $0.11B 11.72%
2012-12-31 $0.01B $0.11B 9.16%
2012-09-30 $0.01B $0.10B 7.75%
2012-06-30 $-0.01B $0.16B -7.09%
2012-03-31 $-0.01B $0.15B -6.29%
2011-12-31 $-0.01B $0.15B -6.12%
2011-09-30 $-0.02B $0.16B -11.28%
2011-06-30 $-0.02B $0.17B -12.81%
2011-03-31 $-0.03B $0.17B -15.32%
2010-12-31 $-0.03B $0.17B -16.02%
2010-09-30 $-0.02B $0.17B -11.31%
2010-06-30 $0.00B $0.19B 2.11%
2010-03-31 $0.01B $0.19B 4.80%
2009-12-31 $0.01B $0.19B 7.02%
2009-09-30 $0.04B $0.19B 20.82%
2009-06-30 $0.03B $0.18B 18.50%
2009-03-31 $0.04B $0.18B 18.72%
2008-12-31 $0.04B $0.18B 19.17%
2008-09-30 $0.02B $0.19B 8.05%
2008-06-30 $0.00B $0.20B 1.10%
2008-03-31 $0.00B $0.19B 1.73%
2007-12-31 $0.00B $0.17B 2.47%
2007-09-30 $0.00B $0.17B 2.56%
2007-06-30 $0.02B $0.17B 15.69%
2007-03-31 $0.02B $0.14B 16.24%
2006-12-31 $0.02B $0.15B 12.90%
2006-09-30 $0.02B $0.16B 13.38%
2006-06-30 $0.02B $0.14B 13.46%
2006-03-31 $0.02B $0.14B 14.15%
2005-12-31 $-0.01B $0.13B -5.81%
Sector Industry Market Cap Revenue
Medical Medical Products Manufacturing $0.776B $0.081B
SurModics, Inc. is a leading provider of surface modification technologies in the areas of biocompatibility, site specific drug delivery, biological cell encapsulation, and medical diagnostics. SurModics partners with the world's foremost medical device, pharmaceutical and life science companies to bring innovation together for better patient outcomes. Recent collaborative efforts include the implementation of SurModics' Bravo drug delivery polymer matrix as a key component of the first-to-market drug-eluting coronary stent. SurModics is also active in the ophthalmology market with a sustained drug delivery system that is currently in human trials for treatment of retinal disease. A significant portion of SurModics' revenue is generated by royalties earned from the sale of our customers' commercial products.
Stock Name Country Market Cap PE Ratio
Medtronic (MDT) Ireland $124.342B 19.06
Abbott Laboratories (ABT) United States $122.048B 24.73
Stryker (SYK) United States $62.796B 23.67
Boston Scientific (BSX) United States $50.730B 25.64
Baxter (BAX) United States $33.541B 21.66
Zimmer Biomet Holdings (ZBH) United States $23.031B 14.94
Smith & Nephew SNATS (SNN) United Kingdom $16.007B 0.00
ResMed (RMD) United States $14.492B 27.64
Canopy Growth (CGC) Canada $8.934B 0.00
Perrigo (PRGO) Ireland $8.884B 13.48
Bio-Rad Laboratories (BIO) United States $8.054B 51.50
Aurora Cannabis (ACB) Canada $6.462B 35.26
Hill-Rom Holdings (HRC) United States $6.201B 19.66
Haemonetics (HAE) United States $5.495B 48.33
Insulet (PODD) United States $4.770B 0.00
ICU Medical (ICUI) United States $4.529B 25.23
Hutchison China MediTech (HCM) China $4.274B 0.00
GW Pharmaceuticals (GWPH) United Kingdom $3.987B 0.00
Agios Pharmaceuticals (AGIO) United States $3.869B 0.00
Neogen (NEOG) United States $3.219B 48.74
National Vision Holdings (EYE) United States $3.101B 61.33
NuVasive (NUVA) United States $2.972B 27.65
Aphria (APHA) $2.572B 0.00
Quidel (QDEL) United States $2.478B 32.30
NxStage Medical (NXTM) United States $1.924B 0.00
Phibro Animal Health (PAHC) United States $1.476B 20.89
AtriCure (ATRC) United States $1.174B 0.00
Cardiovascular Systems (CSII) United States $1.015B 1462.50
VAREX IMAGING (VREX) United States $0.992B 19.93
Meridian Bioscience (VIVO) United States $0.827B 26.35
PetIQ (PETQ) United States $0.803B 22.83
OraSure Technologies (OSUR) United States $0.793B 44.65
Eagle Pharmaceuticals (EGRX) United States $0.755B 24.22
Cerus (CERS) United States $0.719B 0.00
MacroGenics (MGNX) United States $0.710B 0.00
Omeros (OMER) United States $0.623B 0.00
Lantheus Holdings (LNTH) United States $0.590B 18.27
Owens & Minor (OMI) United States $0.558B 6.31
Insys Therapeutics (INSY) United States $0.542B 0.00
LeMaitre Vascular (LMAT) United States $0.518B 25.45
NanoString Technologies (NSTG) United States $0.481B 0.00
TG Therapeutics (TGTX) United States $0.438B 0.00
Evolus (EOLS) United States $0.399B 0.00
Quanterix (QTRX) United States $0.359B 0.00
Utah Medical Products (UTMD) United States $0.327B 21.12
Cytosorbents (CTSO) United States $0.302B 0.00
Neptune Technologies & Bioresources Inc (NEPT) Canada $0.255B 0.00
Surface Oncology (SURF) United States $0.226B 0.00
Rockwell Medical (RMTI) United States $0.211B 0.00
BioLife Solutions (BLFS) United States $0.206B 278.75
Bovie Medical (BVX) United States $0.201B 0.00
Chimerix (CMRX) United States $0.161B 0.00
Conatus Pharmaceuticals (CNAT) United States $0.148B 0.00
Fonar (FONR) United States $0.139B 6.96
Chembio Diagnostics (CEMI) United States $0.104B 0.00
Imprimis Pharmaceuticals (IMMY) United States $0.081B 0.00
United-Guardian (UG) United States $0.079B 16.63
Female Health (VERU) United States $0.079B 0.00
Trinity Biotech (TRIB) Ireland $0.077B 24.40
Oramed Pharmaceuticals (ORMP) Israel $0.070B 0.00
InfuSystems Holdings (INFU) United States $0.067B 0.00
CAS Medical Systems (CASM) United States $0.056B 0.00
Neurotrope (NTRP) United States $0.050B 0.00
ImmuCell (ICCC) United States $0.041B 0.00
Capricor Therapeutics (CAPR) United States $0.028B 0.00
Myomo (MYO) United States $0.025B 0.00
Valeritas Holdings (VLRX) United States $0.021B 0.00
Senestech (SNES) United States $0.019B 0.00
InVivo Therapeutics Holdings (NVIV) United States $0.019B 0.00
Cellectar Biosciences (CLRB) United States $0.009B 0.00
NeuroMetrix (NURO) United States $0.007B 0.00
Akers Biosciences Inc (AKER) United States $0.000B 0.00